Where studies have been carried out, most are in animals or cells
Medication is paired with one-on-one coaching to keep progress on track
Histological studies demonstrated that the extract alleviated the inflammation and maintained the integrity of corneal epithelial cells
With a robust pipeline targeting critical areas such as oncology, cardiovascular diseases, and metabolic disorders, Merck is dedicated to improving patient outcomes and advancing healthcare worldwide
Ipamorelin adjustments are based on symptoms and lab markers: If sleep and recovery improve at 200 mcg, you may stay at that dose If you want more pronounced GH effects, your physician may increase to 250 to 300 mcg A second daily dose (morning, fasted) can be added for enhanced GH support If water retention or joint stiffness develops, the dose may be reduced Key lab work at the 6 to 8 week mark: IGF-1 (confirms Ipamorelin is producing a GH response) thorough metabolic panel HbA1c and fasting glucose Lipid panel Lab work and monitoring Phase 4: Sustained Progress (Weeks 12 through 24) By this stage, both peptides are dialed in and working together effectively
A p-value of less than 0.05 was set as the threshold for clinical significance